HC Wainwright & Co.: Reaffirmed the rating of Novocure (NVCR.US) from neutral to neutral rating, with a target price adjusted from $22.00 to $22.00.
HC Wainwright & Co.：重申NovoCure(NVCR.US)评级，由中性调整至中性评级, 目标价由22.00美元调整至22.00美元。
HC Wainwright & Co.: Reaffirmed the rating of Novocure (NVCR.US) from neutral to neutral rating, with a target price adjusted from $22.00 to $22.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.